Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062175) titled 'An exploratory study on gait training using a combination of the SPIDER and a treadmill' on July 8.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Ibaraki Prefectural University of Health Sciences
Condition:
Condition - Patients with impaired standing and walking ability
No restriction on sex
Age >= 1 year
Height = 1 year
Height < 200 cm (SPIDER frame height limitation)
Weight < 80 kg (Although the SPIDER supports higher loads by distributing body weight across multiple elastic cords, a weight limit of 80 kg is set in this study to ensure participant safety.)
Provided informed consent for training using the SPIDER and a treadmill (for children or individuals unable to provide consent, consent will be obtained from a legally authorized representative)
Currently hospitalized at or receiving outpatient care from the university-affiliated hospital
Key exclusion criteria - Severe comorbidities (e.g., cardiac, hepatic, or renal disease)
Considered unsuitable for participation by the attending physician or the investigators
Target Size - 10
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 08 Day
Anticipated trial start date - 2026 Year 07 Month 31 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071098
Disclaimer: Curated by HT Syndication.
